| (210) | Number of the EPO application | 17796865 |
| (220) | Filing date of the EPO application | 2017.05.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 27/2024, 2024.07.03 |
| (110) | EPO patent number | 3454844 |
| (21) | Number of the application | e 2019 0342 |
| (71) | Name(s) of applicant(s), code of the country | Huyabio International, LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | BISSONNETTE Reid P., US;
ROLLAND Alain, US;
GILLINGS Mireille, US; |
| (73) | Name(s) of owner(s), code of the country | Huyabio International, LLC, US; |
| (54) | Title of the invention | TREATMENT OF COLON CANCER WITH A COMBINATION OF THE HDAC INHIBITOR HBI-8000 AND A PD-L1 INHIBITOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/13 (2006.01.01); A61K 39/21 (2006.01.01); A61K 31/136 (2006.01.01); C07K 14/16 (2006.01.01); C12Q 1/68 (2018.01.01); C12Q 1/70 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/167 (2006.01.01); A61K 31/18 (2006.01.01); A61K 31/395 (2006.01.01); A61K 31/4184 (2006.01.01); A61K 31/506 (2006.01.01); A61K 31/343 (2006.01.01); A61K 31/4045 (2006.01.01); A61K 31/4406 (2006.01.01); A61K 38/15 (2006.01.01); A61K 45/06 (2006.01.01); C07K 16/28 (2006.01.01); A61K 39/395 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.04.30 |
| (30) | Priority | 201662335044 P, 2016.05.11, US; 201662436361 P, 2016.12.19, US |
| (86) | International application | PCT/US2017/032218, 2017.05.11 |
| (87) | International publication | WO 2017/197153, 2017.11.16 |